Inhibitor specificity is also supported by a recent study that showed efflux suppression in ovarian cancer cells by MK-571 and novobiocin correlated with greater expression of MRP1 and BCRP, respectively26. This evidence concerns the gene ABCG2 and ovarian cancer.